-
2025-521199-80-00
4
Patients with previously untreated symptomatic chronic lymphocytic leu
-
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2025-521322-14-00
4
Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation,
-
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
-
2025-521353-16-00
5
Hereditary Angioedema
-
2025-521371-31-00
4
Sepsis
-
2025-521493-33-00
5
bronchiectasis unrelated to cystic fibrosis
-
2025-521567-12-00
4
Vernal Keratoconjunctivitis (VKC)
-
2025-521571-30-00
5
Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
-
2025-521619-37-00
5
Patients ≥75 years old with cT3/T4 rectal adenocarcinoma eligible to r
-
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
-
2025-521671-31-00
9
Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+)
-
2025-521713-57-00
7
Noninfectious Uveitis
-
2025-521891-78-00
5
Adult patients with stage IV non squamous non-small cell lung cancer (
-
2025-521908-22-00
10
EGFR-mutated Non-small Cell Lung Cancer
-
2025-521971-29-00
5
Non Small Cell Lung Cancer (NSCLC)
-
2025-521982-29-00
4
Adult patients with advanced hormone receptor positive (HR+), HER2- br
-
2025-521988-13-00
6
Infection prophylaxis
-
2025-522019-40-00
9
relapsed or refractory BCR::ABL1-positive (Philadelphia positive, Ph+)
-
2025-522049-23-00
6
granulomatosis with polyangiitis and microscopic polyangiitis
-
2025-522060-32-00
4
STEMI (ST elevated Myocardial Infarction)
-
2025-522118-21-00
6
Acute Anterior Uveitis
-
2025-522167-15-00
5
Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC)
-
2025-522176-86-01
5
Moderate Calcific Aortic Valve Stenosis (CAVS)